YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
(RTTNews) - Metagenomi Therapeutics Inc. (MGX), an in vivo genome editing company, on Monday reported second quarter financial results, noting a higher loss owing to increased losses from operations and collaborations. The company speciali…
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday. Price swings ahead of the opening bell are being driven by clinical trial and regulatory updates, as well as trial endpoint misses. In the Green - Premar…
Metagenomi Therapeutics (MGX) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.6. This compares to a loss of $0.68 per share a year ago. These figures are adjusted for non-recurring item…
EMERYVILLE, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for pat…
As Australian shares edge towards a 0.5% advance, buoyed by optimism around geopolitical developments in the Middle East, investors are turning their attention to the potential of penny stocks on the ASX. Although "penny stocks" may seem l…
As the Australian market embraces a "risk-on" sentiment, with precious metals and equity indices experiencing notable hikes, investors are keenly observing opportunities that align with current economic trends. Penny stocks, while often co…
As the global markets navigate a mixed landscape, small-cap and value stocks have emerged as leaders, with indices like the Russell 2000 and S&P MidCap 400 reaching all-time highs. This environment highlights the potential for discerning i…
As the Australian market approaches the end of 2025, it is experiencing a slight dip, with some investors engaging in profit-taking ahead of the holiday season. Despite this minor downturn, opportunities remain for those interested in expl…
As Asian markets navigate a landscape marked by Japan's significant interest rate hike and China's mixed economic signals, small-cap stocks present intriguing opportunities amidst broader market fluctuations. In this context, identifying p…
(RTTNews) - Biotechnology stocks saw notable movement in after-hours trading on Monday, with several companies posting strong gains. Below is a structured look at the key movers and the developments driving their performance. Exicure, Inc.…
Amazon EC2 Trn3 UltraServers powered by AWS's first 3nm AI chip help organizations of all sizes run their most ambitious AI training and inference workloads LAS VEGAS, December 02, 2025--(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Servic…
Amazon stock was higher after the tech giant announced its Trainium3 AI chip is now available for customers of AWS. Continue Reading
Metagenomi, Inc. EMERYVILLE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…
(RTTNews) - Several small-cap biotech and healthcare stocks posted notable gains in after-hours trading on Friday, November 28, 2025, despite limited fresh news flow. Below is a roundup of the key movers. BioAtla Inc. (BCAB) shares surged…
The Australian market is currently navigating a cautious landscape, with ASX futures reflecting concerns over recent inflation data and the looming US Federal Reserve decision. In such an environment, identifying stocks that balance afford…
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.61 per share a year ago. These figures are adjusted for non-recur…
[Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.] ipopba/iStock via Getty Images Biotech company Metagenomi…
As the U.S. stock market navigates through a period of earnings reports and fluctuating commodity prices, investors continue to explore various avenues for potential growth. Penny stocks, often associated with smaller or newer companies, r…
By Stephen Nellis SAN FRANCISCO (Reuters) -Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some of its work in developing gene-editing technologies. The work represents…
The Australian market is facing a potential decline, influenced by the rising gold prices and weaker-than-expected jobs data, which could keep the indices within the 9,000 range. Amid these conditions, investors often look for opportunitie…
A consortium consisting of the Artificial Intelligence Infrastructure Partnership (AIP), MGX, and BlackRock’s Global Infrastructure Partners (GIP) has agreed to acquire Aligned Data Centers for an enterprise value of around $40bn. The deal…
Aligned Data Centers Is an Industry-Leading Provider of Innovative, Sustainable, and Adaptive Digital Infrastructure Powering the World’s Most Complex and Demanding Cloud and AI Workloads NEW YORK & ABU DHABI, United Arab Emirates & DALLAS…
(Bloomberg) -- Global Infrastructure Partners is in advanced talks to acquire Macquarie-backed Aligned Data Centers, targeting a major beneficiary of the AI spending boom in what would be one of the year’s biggest deals, according to peopl…
OpenAI could now be the world's most valuable startup, ahead of Elon Musk's SpaceX and TikTok's parent company ByteDance, after a secondary stock sale designed to retain employees at the ChatGPT maker. Current and former OpenAI employees s…
Image Credits:Thomas Fuller / SOPA Images / LightRocket / Getty Images OpenAI has sold $6.6 billion in shares held by current and former employees, according to a new report from Bloomberg. The sale pushed OpenAI’s total valuation to $500…
MGX, a fund backed by Dubai’s ruling family, will take a 15% stake in TikTok’s U.S. business as part of a restructuring meant to increase American control of the popular video app, the Washington Post reported Friday. The investment, led b…
Sheikh Tahnoon bin Zayed Al Nahyan is part of a deal to buy TikTok in the US - Abdulla Al Bedwawi/UAE Presidential Court The Abu Dhabi royal family is set to buy a stake in TikTok’s US business under a deal brokered by Donald Trump. MGX, a…
MGX, a United Arab Emirates-based investor in AI and advanced technologies, has joined Silver Lake as a co-investor in acquiring a 51% stake in Altera. Based in California, US, Altera specialises in programmable semiconductor solutions. In…
(Reuters) -Analytics firm Databricks (DATB.PVT) was on track to hit $4 billion in annual revenue, up more than 50% from the prior year, on the back of surging demand for its AI products. In the second quarter, the company serving around 15…
Mount Gibson Iron Ltd (MGX) reported its Q4 2025 earnings, showcasing a strategic pivot towards diversification and growth despite the absence of earnings forecasts. The company’s shares rose by 5.33% following the earnings call, closing a…
METAGENOMI INC (NASDAQ:MGX [https://www.chartmill.com/stock/quote/MGX]) REPORTS Q2 2025 EARNINGS: REVENUE BEATS ESTIMATES, LOSS NARROWS Metagenomi Inc, a precision genetic medicines company, reported its second-quarter 2025 financial resul…
Metagenomi, Inc. (NASDAQ:MGX) is one of the 11 Best New Penny Stocks to Buy Right Now. On May 14, Metagenomi, Inc. (NASDAQ:MGX) announced that it is presenting three abstracts at the American Society of Gene & Cell Therapy (ASGCT) 28th Ann…
[Artificial intelligence circuit board 5] Jonathan Kitchen * Anthropic, an AI startup widely seen as a rival to OpenAI, is said to have had early talks for a new funding round that would more than double its valuation to more than $150B. *…
Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced the presentation of 3 abstracts at the American Society of Gene & Cell Therapy/ASGCT 28th Annual Meeting, which was…
The U.S. stock market has been navigating a wave of uncertainty, with recent tariff threats from President Trump causing fluctuations across major indices such as the Dow Jones, S&P 500, and Nasdaq. Amid these broader market dynamics, penn…
- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate the ability to specif…